The paralysed man can stand again after receiving experimental stem cell therapy. He was given an injection of neural stem ...

Eli Lilly (LLY) CEO David Ricks got a 10% raise in 2024, as a surge in demand for weigh-loss drugs has propelled the pharma giant into the most valuable pharmaceutical company in the world.

Presiding over the upward trajectory of Eli Lilly over the last eight years has been paying off nicely for CEO David Ricks ... led by breast cancer therapy Verzenio and heart failure treatment ...

The stem cell treatment for blinding cornea injuries — called cultivated autologous limbal epithelial cell (CALEC) transplantation — was developed at Mass Eye and Ear. It consists of removing stem ...

Every month, roughly 100,000 people buy Zepbound directly from Eli Lilly through its website. "It's about the size of a small city," says David Ricks, Eli Lilly's CEO. That's about 10% of the 1 ...

SUGAR LAND, Texas--(BUSINESS WIRE)--FDA has authorized Hope Biosciences’ adipose-derived mesenchymal stem cells (HB-adMSCs ... Hope Biosciences’ proprietary cell therapy product has been ...

A new stem cell therapy has repaired blinding damage to the cornea in 93% of patients in an early clinical trial. However, severe injuries, such as those caused by chemical burns or infections ...

Get Instant Summarized Text (Gist) A clinical trial tested a stem cell therapy, CALEC, for corneal injuries, showing it is feasible and safe. The treatment restored the cornea's surface in 50% of ...

Novel stem cell therapy repairs 'irreversible' corneal damage in clinical trial Date: March 4, 2025 Source: Mass Eye and Ear Summary: Results from a phase 1/2 clinical trial of a novel stem cell ...